(Q43892494)

27 November 2017

Evaluation of renal function following treatment with 5-aminosalicylic acid derivatives in patients with ulcerative colitis (English)

1 reference

27 November 2017

Mahmud N

1

1 reference

27 November 2017

O'Toole D

2

1 reference

27 November 2017

O'Hare N

3

1 reference

27 November 2017

Freyne PJ

4

1 reference

27 November 2017

Weir DG

5

1 reference

27 November 2017

Kelleher D

6

1 reference

27 November 2017

language of work or name

English

0 references

publication date

1 February 2002

1 reference

Alimentary Pharmacology & Therapeutics

27 November 2017

1 reference

27 November 2017

16

1 reference

27 November 2017

2

1 reference

27 November 2017

207-215

1 reference

Sulfasalazine. Adverse effects and desensitization

27 November 2017

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2002.01155.X

A controlled therapeutic trial of long-term maintenance treatment of ulcerative colitis with sulphazalazine (Salazopyrin).

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2002.01155.X

Metabolism and urinary excretion of 5-amino salicylic acid in healthy volunteers when given intravenously or released for absorption at different sites in the gastrointestinal tract

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2002.01155.X

Distribution and metabolism in healthy volunteers of disodium azodisalicylate, a potential therapeutic agent for ulcerative colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2002.01155.X

An oral preparation to release drugs in the human colon

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2002.01155.X

Measurement of gastrointestinal pH profiles in normal ambulant human subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2002.01155.X

Mesalazine associated nephrogenic diabetes insipidus presenting as weight loss

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2002.01155.X

Nephrotic syndrome associated with sulphasalazine

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2002.01155.X

Nephrotic syndrome after treatment with 5-aminosalicylic acid

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2002.01155.X

5-Aminosalicylic acid-associated renal tubular acidosis with decreased renal function in Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2002.01155.X

Systemic levels of free 5-aminosalicylic acid depend on the nature of the 5-aminosalicyclic acid derivative and not on disease activity or extent in patients with inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2002.01155.X

Renal tubular dysfunction in patients with inflammatory bowel disease treated with aminosalicylate

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2002.01155.X

Reversible Renal Failure and Nephrotic Syndrome Associated with Nonsteroidal Anti-Inflammatory Drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2002.01155.X

Microalbuminuria and associated cardiovascular risk factors in the community

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2002.01155.X

Glutathione transferase in the urine: a marker for post-transplant tubular lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2002.01155.X

A simple index of Crohn's-disease activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2002.01155.X

Microalbuminuria in inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2002.01155.X

Comparison of delayed release 5 aminosalicylic acid (mesalazine) and sulphasalazine in the treatment of mild to moderate ulcerative colitis relapse

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2002.01155.X

10.1046/J.1365-2036.2002.01155.X

21 January 2018

Identifiers

DOI

1 reference

27 November 2017

1 reference